期刊文献+

BRD7在非小细胞肺癌组织中的表达及临床意义 被引量:2

Expression and Clinical Significance of Bromodomain-containing Protein 7 in Non-small Cell Lung Cancer
下载PDF
导出
摘要 背景与目的溴区包含蛋白7(bromodo main-containing protein7,BRD7)基因属于bromodomain家族成员,该家族的大多数成员与上皮类肿瘤的发生密切相关。本研究旨在探讨BRD7在非小细胞肺癌(non-small cell lung cancer,NSCLC)中的表达及其临床意义。方法采用免疫组化法检测101例NSCLC癌组织及其33例正常肺组织中BRD7的表达情况。结果 BRD7在NSCLC组织中的阳性表达率明显高于正常肺组织;BRD7在淋巴结转移组阳性表达率高于无淋巴结转移组;BRD7的阳性表达率随着TNM分期的升高而升高。BRD7的阳性表达与患者年龄、性别、吸烟情况、病理类型、分化程度无关(P>0.05)。结论 BRD7在NSCLC中有较高的表达率,除了与淋巴结转移有关外,还与TNM分期有关,提示BRD7可能与肺癌的发生、发展和转移有关。 Background and objective The bromodomain-containing protein 7 (BRD7) gene belongs to the bromodomain family. The majority of the members of this family are closely related to epithelial tumors. The aim of this study is to explore BRD7 expression and its clinical significance in non-small cell lung cancer (NSCLC). Methods BRD7 protein expression was detected in tissues samples from 101 NSCLC cases and 33 normal lung tissue samples using streptavidin-peroxidase immunohistochemistry. Results BRD7 expression was significantly higher in cancer tissues than that in normal lung tissues. Positive BRD7 expression in the lymph node metastasis group was significantly higher than that in the non-lymph node metastasis group. The positive expression rate of BRD7 increased with the increasing Tumor-Nodes-Metastasis (TNM) stage. No significant differences in positive BRD7 expression were observed with age, smoking, gender, pathology type, and degree of differentiation among the NSCLC patients (P0.05). Conclusion BRD7 is highly expressed in NSCLC. In addition to the degree of differentiation and extent of lymphatic metastasis, BRD7 expression is correlated with TNM stage, which indicates that BRD7 may be related to the occurrence, development, and metastasis of lung cancers.
作者 陈龙 喻风雷
出处 《中国肺癌杂志》 CAS 2011年第10期830-834,共5页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 溴区包含蛋白7 免疫组化 Lung neoplasms Bromodomain-containing protein 7 Immunohistochemistry
  • 相关文献

参考文献13

  • 1Zhou J, Ma J, Zhang BC, et al. BRD7, a novel bromodomain gene, inhibits G,-S progression by transcriptionally regulating some important molecules involved in Ras/MEK/ERK and Rb/E2F pathways. J Cell Physiol, 2004, 200(1 ): 89-98. 被引量:1
  • 2Peng C, Liu HY, Zhou M, et al. BRD7 suppresses the growth of Nasopha- ryngeal Carcinoma cells (HNE 1) through negatively regulating beta-catenin and ERK pathways. Mol Cell Biochem, 2007, 303(1-2): 141-149. 被引量:1
  • 3李凡,谢滨萱,张润希,杨亚荣,薛炀,马锐,蒋金鑫.肺癌的基因诊断和基因治疗[J].职业与健康,2010,26(1). 被引量:2
  • 4郑智,潘铁成,李军,陈涛,宋定伟,易军.Ⅰ期非小细胞肺癌淋巴结微转移与预后关系的Meta分析[J].癌症,2004,23(2):185-188. 被引量:13
  • 5Peng C, ZhouJ, Liu et al. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. J Cell Biochem, Z006j 97(4): 882-892. 被引量:1
  • 6Drost J, Mantovani F, Tocco F, et al. BRD7 is a candidate tumour suppressor gene required for P53 function. Nat Cell Biol, 2010, 12(4): 380-389. 被引量:1
  • 7彭聪,李小玲,周鸣,刘华英,王莉莉,张秋红,杨一新,吴尚辉,黄柏英,熊炜,李桂源.鼻咽癌相关基因BRD7对鼻咽癌细胞CNE1的影响[J].生物化学与生物物理进展,2005,32(9):842-849. 被引量:3
  • 8余鹰谢,奕曹利,张必成,周鸣,李桂源,public.cs.hn.cn.一个新鼻咽癌抑瘤候选基因的克隆及其功能初步分析[J].生物化学与生物物理进展,2000,27(3):319-324. 被引量:32
  • 9Kaeser MD, Aslanian A, Dong MQ, et al. BRD7, a novel PBAF-specific SWI/ SNF subunit, is required for target gene activation and repression in embry- onic stem cells. J Biol Chem, 2008, 283(47): 32254-32263. 被引量:1
  • 10Hendricks KB, Shanahan F, Lees E. Role for BRG1 in cell cycle control and tumor suppression. Mol Cell BioI, 2004, 24(1): 362-376. 被引量:1

二级参考文献44

  • 1冉丕鑫,李岱宗,陈顺存,钟南山.肺癌基因治疗[J].中华结核和呼吸杂志,1995,18(5):270-273. 被引量:3
  • 2邱忠民.肺癌基因治疗的研究进展[J].国外医学(呼吸系统分册),1996,16(2):89-92. 被引量:6
  • 3张新 贾友明.肺癌的分子生物学基础与基因治疗[J].实用肺科杂志,1996,3:5-7. 被引量:1
  • 4Mistudomi T, Takahashi T. Genetic Abnormalities in Lung Cancer and their Prognostic Implication. Cancer Chemother, 1996,23 : 990 - 996. 被引量:1
  • 5Antonia SJ, Sotomayor E. Gene therapy for lung cancer, user opin ol, 2000,12 : 138 - 142. 被引量:1
  • 6Rozengurt E. Autocrine loops, signal transduction, and cellcycle aormalitiesinthe molecular biology of lung cancer. Curt Opin Oncol, 1999,1 : 116 - 122. 被引量:1
  • 7Pearson AS, Spitz FR, Swisher, SG, et al. Up-regalation of the proapoptotic mediators Bax and Bak afrer adenovirus-mediated TP53 gene transfer in lung cancer cells. Clin Cancer Res,2006,6:887 - 890. 被引量:1
  • 8Guarini A , Riera L , Cignetti A, et al. Transfer of the interleukin gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T2cell receptor associated signalt ransduction molecules. Blood, 1997,89:216 -218. 被引量:1
  • 9Tan Y, Xu M , Wang N , et al. IL-22 gene therapy of advanced lung cancer patient s. Anticancer Res, 1996,16 : 1993 - 1998. 被引量:1
  • 10Kwong YL ,Chen SH, Kosai K, et al. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest, 1997 ; 112 : 1332 - 1337. 被引量:1

共引文献45

同被引文献41

  • 1Jemal A,Siegel R,Xu J,et al. Cancer statistics,2010. CA Cancer J Clin ,2010,60:277-300. 被引量:1
  • 2Park DS, Hwang KE, Shim H, et al. Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions. Clin Exp Metastasis, 2012,29:83-89. 被引量:1
  • 3Hasanovic A, Ang D, Moreira AL, et al. Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma. Lung Cancer, 2012,77 : 299- 305. 被引量:1
  • 4Pan S, Wang F, Huang P, et al. The study on newly developed McAb NJ001 specific to non-small cell Lung cancer and its biological characteristics. PLoS One ,2012,7 : e33009. 被引量:1
  • 5Travis WD, Rekhtman N. Pathological diagnosis and classification of lung cancer in small biopsies and cytology : strategic management of tissue for molecular testing. Semin Respir Crit Care Med,2011,32 :22-51. 被引量:1
  • 6Tacha D, Yu C, Bremer R, et al. A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma. Appl Immunohistochem Mol Morphol, 2012,20:201- 207. 被引量:1
  • 7Yang L, Lin M, Ruan WJ,et al. Nkx2-1 : a novel tumor biomarker of lung cancer. J Zhejiang Univ-Sci B ( Biomed & Biotechnal) , 2012,13:855-866. 被引量:1
  • 8Fujiwara S, Nawa A, Nakanishi T, et al. Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor. Hum Patho1,2010,41:560-565. 被引量:1
  • 9Kontzoglou K, Palla V, Karaolanis G, et al. Correlation between Ki67 and breast cancer prognosis. Oncology,2013,84:219-225. 被引量:1
  • 10Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Ciin, 2013, 63(1): 11-30. 被引量:1

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部